MTOR and neoplasm: Combined use of these treatment modalities with mTOR inhibitors that are more effective at targeting CSCs thereby renders more effective tumor destruction, better disease control and overcome the CSCs-mediated tumor resistance associated with the use of traditional agents (Sehl et al., 2009).